NYC Business News

"> ">

Did NYC Comptroller's Office Hurt This Black Business?

In this Voices of NYC Op-Ed, Sam Eric Blackwell examines the disparity in city contracting opportunities for Black-owned businesses through the experience of East New York restaurant Fusion East. Blackwell questions how owner Andrew Walcott’s request for help collecting unpaid school invoices became a controversy surrounding his business, and calls for transparency about the treatment of Black-owned vendors and the consequences of government scrutiny.

"> ">

Kota the Friend & TIDAL Partner for Flight Night NYC

Brooklyn-born independent hip-hop artist Kota the Friend is bringing Flight Night back to New York City for a two-day music and arts experience December 10–11, 2026, with TIDAL as presenting partner. Organized through Kota's FLTBYS brand, the event begins December 10 with Local Art Dealer IRL, an invitation-based gathering for independent musicians, artists, managers and creative entrepreneurs focused on ownership and direct-to-fan opportunities. On December 11, Kota will headline a concert at SOB's in Manhattan alongside Statik Selektah, Neptune XXI, Iman Nunez and Life of Thom. Flight Night has previously hosted events in cities across the United States and Europe. Concert tickets are available through FlightNight.com, while interested artists can apply to attend the gathering.

"> ">

Hyatt Plans 1,800-Room StandardX Hotel in Times Square

Hyatt Hotels Corporation and Extell Development Company have announced plans for The StandardX Times Square, an approximately 1,800-room hotel at 255 West 45th Street in Manhattan's Theater District. Expected to open in the second half of 2028, the property will mark the first North American location for The StandardX brand. The development is planned to include an enclosed free-fall thrill ride, an observation deck more than 1,000 feet above Manhattan, a rooftop pool, restaurants, bars and nightlife venues. Developed by Extell, the project will combine hotel accommodations with entertainment attractions accessible to visitors and New Yorkers. The companies say additional details about the property's design, dining concepts and creative collaborations will be announced later.

"> ">

Cleary Gottlieb Names NY Based Mark Pflug M&A Partner

Cleary Gottlieb Steen & Hamilton has announced that Mark Pflug has joined the international law firm as a New York-based partner in its Americas M&A and Private Equity Transactions groups. Pflug brings approximately two decades of experience advising private equity sponsors and public and private companies on acquisitions, investments, recapitalizations, joint ventures and other complex transactions. His practice spans healthcare, life sciences, real estate services, industrial businesses, technology, media and telecommunications, including cross-border deals in Europe and Asia. His appointment follows several other senior additions to Cleary's M&A practice during 2026, including Niqui Kohli, Emmanuel Enrici and Matthew Schwartz. The firm says the expansion strengthens its capabilities in private equity and corporate transactions.

"> ">

NYU Study Finds New Drug Reduces Cancer Death Risk

An international phase 3 clinical trial led by researchers at NYU Langone Health's Perlmutter Cancer Center found that sacituzumab tirumotecan, a targeted cancer drug, improved outcomes for patients with previously treated advanced or recurrent endometrial cancer. Among 776 women, those assigned to the drug had a 41% lower relative risk of disease progression and a 32% lower relative risk of death compared with patients receiving standard chemotherapy. Tumor responses occurred in 35.1% of patients receiving sacituzumab tirumotecan, compared with 17.3% in the chemotherapy group. The findings, scheduled for presentation October 26 and publication in The Lancet, could inform future treatment guidelines, although regulatory status and longer-term outcomes require clarification.

"> ">

NYU Langone Names Ishwaria Subbiah to Cancer Role

NYU Langone Health has appointed Dr. Ishwaria Subbiah as director of the Symptom Management Program for hematology and medical oncology at Perlmutter Cancer Center, effective November 1, 2026. She will also serve as an associate professor of medicine at NYU Grossman School of Medicine. A specialist in supportive and palliative care and integrative oncology, Dr. Subbiah will lead efforts to improve management of cancer treatment side effects, including pain, fatigue, nausea and neuropathy. She brings more than 16 years of patient care experience and previously held a faculty position at MD Anderson Cancer Center. Her work includes clinical trials, technology-enabled symptom monitoring and programs designed to improve patients' quality of life during treatment.

"> ">

Weill Cornell Gets $8.2M for Male Birth Control Pill

Weill Cornell Medicine has received an $8.2 million federal grant to advance an experimental male birth control pill designed to temporarily stop sperm from swimming. Led by pharmacology professors Dr. Jochen Buck and Dr. Lonny Levin, the four-year research project aims to develop an on-demand contraceptive that men could take approximately 30 minutes before sex, with effects lasting six to eight hours. Earlier preclinical research found that blocking an enzyme involved in sperm movement could prevent pregnancy in experimental models. The new funding will support drug formulation, manufacturing, safety studies and preparations for an initial human clinical trial. The pill is not approved for human use, and researchers must establish its safety and effectiveness before it could become a contraceptive option.

"> ">

NY AG James Secures $6M in Crypto Fraud Settlements

Thousands of New Yorkers who invested in cryptocurrency ventures promoted through community networks are at the center of a major financial fraud enforcement case. Attorney General Letitia James has secured nearly $6 million in settlements from four promoters of NovaTech and AWS Mining, businesses accused of operating pyramid schemes that disproportionately targeted Haitian and other immigrant communities. More than 11,000 New Yorkers invested in the ventures, which advertised unusually high returns and recruitment incentives. The promoters have also been permanently barred from participating in securities, commodities and cryptocurrency industries. Separately, James is seeking $1.3 billion in damages and disgorgement from NovaTech founders Cynthia and Eddy Petion following a 2025 default judgment. The settlements are intended to benefit victims, although individual reimbursement amounts have not been announced.

"> ">

Van Wyck $1.4B Upgrade Opens New Airport Lanes

For years, New Yorkers and visitors traveling to and from John F. Kennedy International Airport have faced frustrating traffic delays on the Van Wyck Expressway, where heavy airport traffic, merging vehicles and years of construction have contributed to slow-moving commutes and unpredictable travel times. Now, new high-occupancy vehicle lanes have opened in both directions as part of a $1.4 billion modernization project designed to ease one of Queens' most persistent transportation bottlenecks. The lanes accommodate buses, taxis, for-hire vehicles and private cars carrying at least two people, including the driver. Redesigned entrance and exit ramps are also intended to reduce traffic backups, while upgraded drainage systems aim to prevent flooding-related disruptions. With major highway construction substantially complete, the improvements are expected to provide smoother, more reliable access to JFK, although actual reductions in travel times have yet to be measured.